Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SNMRY | RIVN |
|---|---|---|
| Price | $12.39 | $14.60 |
| Change today | ▼ 1.67% | ▲ 2.10% |
| Market cap | $21.13B | $21.14B |
| Return, 3 months | -13.0% | -11.5% |
| Return, year to date | -3.7% | -25.9% |
| Return, 1 year | +8.4% | +8.1% |
| P/E (TTM) | 16.1 | -5.6 |
| P/B | 2.2 | 4.1 |
| P/E percentile vs own 5y | – | 9th |
| Dividend yield | 5.51% | – |
| Revenue growth (YoY, latest qtr) | – | +27.2% |
| Net profit growth (YoY) | – | +24.9% |
| Gross margin | – | 7.5% |
| Operating margin | – | -60.1% |
| Net margin | – | -55.0% |
| Return on equity | – | -57.9% |
| Analyst target vs. price | – | +28.4% |
| Analyst buy share | – | 42% |
| RSI (14) | 34 | 41 |
| 30-day volatility | 14.8% | 33.0% |
| Max drawdown, 1 year | -19.8% | -42.5% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
